Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
This guide clarifies which investors benefit most from target date funds versus index funds, focusing on goals and involvement level.
26,623 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
AMD posts a 55% month gain as AI data center demand accelerates, eclipsing Intel’s advance. The move sparks a debate ...
Measles poses a bigger public health risk than Ebola as the World Cup attracts millions to U.S. host cities. Official...
As UAD 3.6 rolls out, lenders should view reset as a strategic inflection point — a chance to retool data, adjust ris...
A broad coalition pressed the Senate on June 16 to explicitly ban sports and casino-style prediction markets in the D...
RFK Jr. backs a plan to immediately hike payroll taxes to close Social Security's funding gap, triggering political d...
Snap faces another disappointing quarter as ad revenue slows and user growth stalls. With mounting headwinds, many an...
Projections show a potential drop to 78% of promised Social Security benefits by 2032 if rules stay the same. Retiree...
A high-income professional taps a tax-smart 401(k) path—after-tax contributions plus in-plan Roth conversions—to turn...
Quantum stocks jump on optimism about next-gen tech, yet analysts caution that lofty valuations outpace current earni...
Regulators weigh new crypto rules as quantum risk looms in 2026. CryptoQuant founder Ki Young Ju’s idea to freeze dor...
A real-world case shows how the disabled adult child benefit can unlock substantial monthly income when a parent clai...